Skip to content
Magazine
Sunday, August 3, 2025
SUBSCRIBE
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
SUBSCRIBE

Parliament and WTO on track to waive COVID-19 vaccine patents

Marta Pacheco by Marta Pacheco
10 June 2021
in European Parliament News
European union flag against parliament in Brussels, Belgium

European union flag against parliament in Brussels, Belgium

Brussels (Brussels Morning) The European Parliament voted today to call on the World Trade Organisation (WTO) to temporarily waive intellectual property (IP) rights protection for COVID-19 vaccines and treatments. The vote was reinforced by yesterday’s WTO decision to start negotiations on exempting vaccine patents.

After the US unexpectedly voiced its support for COVID-19 vaccines waivers, the EU felt the pressure to follow suit, despite initial reluctance to support such measure.

“We made it! The European Parliament’s plenary calls for a comprehensive approach to defeat COVID-19 with TRIPS waiver, technology transfer and using contracts as important leverage”, an exultant MEP Bernd Lange (S&D) announced.

“Now it’s time for Council and Commission to move on waivers with the WTO”, he added.

MEPs have broadly agreed that voluntary licencing, know-how and technology transfer to countries with vaccine-producing industries is the most important and effective way to scale and speed up global production in the long term.

WTO’s greenlight

Yesterday, an agreement by WTO members to start negotiations on the TRIPS waiver gave extra impetus to the Parliament’s decision — and also applied extra pressure on the EU — to support exports of vaccines to developing countries.

The WTO’s TRIPS Council agreed to move ahead with a “text-based process”, effectively opening the door to negotiations over a proposal to waive intellectual property associated with COVID-19 tests, treatments and vaccines, Geneva-based trade officials said. 

The WTO TRIPS agreement enables members to waive an obligation in exceptional circumstances by consensus-based decision-making.

The World Health Organization has repeatedly condemned unequal access to vaccines, noting that rich countries have seized more COVID-19 vaccines than required by actual populations, while developing countries have obtained only a small fraction of the doses so far distributed and used worldwide.

Inter-institutional relations

At a joint press conference, on 8 May with Council President Charles Michel and Portugal’s PM António Costa, Commission President Ursula von der Leyen said the EU was “open to discuss” a temporary IP exemption.

The Commission’s chief insisted on a public-private partnership proposal, noting that production bottlenecks, investment in global manufacturing and contributions to the COVAX scheme still “remain key priorities for expanding global access to vaccines”.

In their responses about how to address production bottlenecks, MEPs called on the EU “to rapidly eliminate export barriers and to replace its own export authorisation mechanism with export transparency requirements”.

MEPs persisted with their demands for full disclosure of future advance purchase agreements, particularly for next generation vaccines, and said such contracts should include transparency requirements for suppliers.

Finally, the Parliament called for the urgent production and delivery of 11 billion doses of COVID-19 vaccines, much needed to immunise 70% of the world’s population. So far, only a fraction of that amount has been produced.

World Bank

Despite the WTO’s position and the positive developments within the Parliament, the move to waive IP rights from COVID-19 vaccines and treatments was received coolly by World Bank President David Malpass, who on Tuesday declared that it could “hamper innovation in the pharmaceutical sector”, Reuters reported.

Related News:

  • WTO seeks to temporarily waive IP on COVID-19 jabs
  • EU doubts value of COVID-19 vaccine IP waiver as WTO wavers
  • WTO head criticises EU’s vaccine export restrictions
  • COVID vaccine ready early next year, says UK vaccine chief
Tags: Biweekly MartaBrussels DirectNews
Next Post
Waving flags of the European Union EU and China in front of a modern skyscraper facade. 3D rendering

Veteran German diplomat warns EU must speak to China with one voice

Latest post

EU-elections-UK

EU elections: UK looks on from the “outside”

1 year ago
Galeries-Royales-Saint-Hubert

What Makes Galeries Royales Saint-Hubert an “Institution”?

1 year ago

Most Read

    Follow Brussels Morning
    Facebook Twitter Youtube Linkedin

    Browse Important News

    Belgium News
    Brussels News
    Culture and Society News
    Economy News
    EU Institutions News
    European Commission News
    European Council News
    European Parliament News
    Europe News
    Health And Fitness News
    Southeast Europe News
    Sustainable Perspective
    World News
    Diplomacy News
    US Elections News

    About Us

    Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

    More Info

    • About Us
    • Advertise With Us
    • Contact Us
    • Cookies Policy

    Join Our Newsletter

    Brussels Morning Newspaper – All Rights Reserved © 2024

    No Result
    View All Result
    • Home
    • About Us
    • Belgium News
      • Belgium Police News
      • Brussels News
    • Brussels Bubble
      • European Parliament News
      • European Commission News
      • European Council News
    • Wider Europe
      • Member States
    • World News
    • Business & Society
    • Europe With Transparency
    • Culture & Society
    • Policy Talks
      • Place de la Bourse
      • The Macro-Economist
      • Sustainable Perspective
      • Ambassador’s Corner
      • The American Angle
      • Southeast Europe
    • Print Magazine

    Brussels Morning Newspaper - All Rights Reserved © 2020

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT